Aciphin IM Injection 1 gm/Vial

Aciphin is a third-generation cephalosporin antibiotic containing Ceftriaxone Sodium (1 gm/vial) manufactured by ACI Limited. Priced at ৳191.29 per vial, this injection treats bacterial infections like pneumonia, meningitis, and urinary tract infections. Its broad-spectrum action targets both gram-positive and gram-negative bacteria effectively.

Available as an IM Injection, Aciphin requires proper storage below 30°C. The drug’s 6-9 hour half-life allows once-daily dosing for most patients. Common uses include surgical prophylaxis and treating skin/soft tissue infections. Explore Aciphin uses and proper administration guidelines for optimal results.

Indications: Aciphin is prescribed for:

• Lower respiratory infections
• Bacterial sepsis
• Gonorrhea
• Bone/joint infections
• Meningitis

Dosage varies between adults (1-2 gm/day) and children (50-75 mg/kg). Always complete the full course to prevent antibiotic resistance.

Side Effects may include diarrhea, skin rashes, or elevated liver enzymes. Rarely, thrombocytopenia or neutropenia occurs. Consult doctors if severe reactions emerge. Pregnant/nursing women should use Aciphin cautiously despite low breastmilk excretion levels.

For alternatives, consider other Ceftriaxone Sodium brands like Aciphin 250 mg/vial or 500 mg/vial. Visit Medexly for detailed drug comparisons and authentic pharmaceutical products from ACI Limited.

Adults: 1-2g IV/IM daily (max 4g). Pediatrics: 50-75 mg/kg daily (max 2g). Meningitis: 100 mg/kg. Gonorrhea: Single 250 mg dose. Surgical prophylaxis: 1g preoperatively. Treatment duration typically 4-14 days, extend 2 days post-symptom resolution.

Aciphin is generally well tolerated. A few side effects such as gastro-intestinal effects including diarrhea, nausea and vomiting, stomatitis and glossitis; cutaneous reactions including rash, pruritus, urticaria, edema and erythema multiforme; hematologic reactions including eosinophilia, thrombocytopenia, leucopenia, anemia and neutropenia; hepatic reactions including elevations of SGOT or SGPT, bilirubinemia; CNS reactions including nervousness, confusion, sleep disturbances, headache, hyperactivity, convulsion, hypertonia and dizziness were reported. Local phlebitis occurs rarely following intravenous administration but can be minimized by slow injections over 2-4 minutes.

Pregnancy category N/A. Use only if potential benefit justifies risk. Caution in lactation – may cause infant diarrhea or fungal infections.

Perform allergy testing. Monitor CBC and renal/hepatic functions during prolonged therapy. Ensure adequate hydration. Dose adjustment may needed in elderly.

Pediatrics: Safe above 1 month. Geriatric: Adjust dose based on renal function. Renal impairment: No adjustment needed. Hepatic impairment: Reduced biliary excretion.

There is no specific antidote. Treatment of overdosage should be symptomatic.